Oral delivery of polypeptides

Details for Australian Patent Application No. 2007336189 (hide)

Owner Ablynx N.V.

Inventors Dolk, Edward; Saunders, Michael John Scott; De Haard, Johannes Joseph Wilhelmus; Hoogenboom, Hendricus Renerus Jacobus Mattheus; Lasters, Ignace Joseph Isabella

Agent Shelston IP

Pub. Number AU-A-2007336189

PCT Pub. Number WO2008/074868

Priority 60/875,990 20.12.06 US; PCT/ EP2007/060850 11.10.07 EP

Filing date 20 December 2007

Wipo publication date 26 June 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/074868 Priority application(s): WO2008/074868

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007336190-Surface treatment method for nanoparticles

2007336188-Anti-Fc-receptor single domain antibodies (Nanobodies-tm) and therapeutic use